• News

"First Time in US: Mount Sinai Treats Liver Cancer With Radiopaque Beads"

  • Managed Care Magazine
  • New York, NY
  • (March 22, 2016)

The Mount Sinai Hospital is the first center in the US to use a new cancer treatment consisting of luminescent chemotherapy-filled beads injected into tumors via the wrist. The minimally invasive treatment is available for patients with inoperable and difficult-to-treat liver cancer. “In the past, we had no way to verify where the beads were placed in the blood vessels or whether they remained in the intended location over time,” said Edward Kim, MD, director of interventional radiology at The Mount Sinai Hospital. “Now we can see the location and adjust if a portion of the tumor has been missed while the patient is on the table without repeating the procedure. This is what we call precision targeting of tumors.” Learn more.